Knowing who is at risk for a cardiac event after surgery may soon be easier. Drs Cassoobhoy and Walton-Shirley discuss the VISION trial presented at ACC.17.
What should primary care docs know about LDL-lowering effects of the PCSK9 inhibitor evolocumab? A leading cardiologist discusses results of the FOURIER trial.
8 min
About Medscape Internal Medicine Podcast
From the publisher's feed
Latest medical news and features from Medscape Internal Medicine